TNFα cooperates with the protein kinase A pathway to synergistically increase HIV-1 LTR transcription via downstream TRE-like cAMP response elements

Virology

Volumn 237, Issue 2, 1997, Pages 422-429

  Rabbi, Mohammed F ^a   Al Harthi, Lena ^a   Roebuck, Kenneth A ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; CELL LINE; GENETIC TRANSCRIPTION; GENETICS; MONOCYTE; PHYSIOLOGY; SECOND MESSENGER; VIROLOGY; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

CELL LINE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; MONOCYTES; SECOND MESSENGER SYSTEMS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; VIRUS REPLICATION;

EID: 0030612738     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8798     Document Type: Article

References (44)

1. Angel P., Imagawa M., Chiu R., Stein B., Imbra R. J., Rahmsdorf H. J., Jonat C., Herrlich P., Karin M. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell. 49:1987;729-739.
2. Bannister A. J., Kouzarides T. The CBP co-activator is a histone acetyltransferase. Nature. 384:1996;641-643.
3. Benbrook D. M., Jones N. C. Heterodimer formation between CREB and JUN proteins. Oncogene. 5:1990;295-302.
4. Blair W. S., Fridell R. A., Cullen B. R. Synergistic enhancement of both initiation and elongation by acidic transcription activation domains. EMBO J. 15:1996;1658-1665.
5. Brenner D. A., O'Hare M., Angel P., Chojkier M., Karin M. Prolonged activation of Jun and collagenase genes by TNFα Nature. 337:1989;661-663.
6. Brown D. A., Xu X., Nerenberg M. Genomic footprinting of HTLV type 1 and HIV type 1 in human T cell lines. AIDS Res. Hum. Retroviruses. 12:1996;829-832.
7. Cannon P., Kim S. H., Ulich C., Kim S. Analysis of Tat function in human immunodeficiency virus type 1-infected low-level-expression cell lines U1 and ACH-2. J. Virol. 68:1994;1993-1997.
8. Chatton B., Bocco J. L., Goetz J., Gaire M., Lutz Y., Kedinger C. Jun and Fos heterodimerize with ATFa, a member of the ATF/CREB family and modulate its transcriptional activity. Oncogene. 9:1994;375-385.
9. Chowdhury I. H., Koyangi Y., Horiuchi S., Hazeki O., Ui M., Kitano K., Golde D. E., Takada K., Yamamoto N. cAMP stimulates human immunodeficiency virus (HIV-1) from latently infected cells of monocye-macrophage lineage: Synergism with TNFα Virology. 194:1993;345-349.
10. De Cesare D., Vallone D., Caracciolo A., Sassone-Corsi P., Nerlov C., Verde P. Heterodimerization of cJun with ATF-2 and c-Fos is required for positive and negative regulation of the human urokinase enhancer. Oncogene. 11:1995;365-376.
11. Finnegan A., Roebuck K. A., Nakai B. E., Gu D. S., Rabbi M. F., Song S., Landay A. L. IL-10 cooperates with TNFα to activate HIV-1 from latently and acutely infected cells of monocyte/macrophage lineage. J. Immunol. 156:1996;841-851.
12. Gaynor R. B. Cellular transcription factors involved in the regulation of HIV-1 gene expression. AIDS. 6:1992;347-353.
13. Gonzalez G. A., Menzel P., Leonard J., Fischer W. H., Montminy M. R. Characterization of motifs which are critical for activity of the cyclic AMP-responsive transcription factor CREB. Mol. Cell. Biol. 11:1991;1306-1312.
14. Granowitz E. V., Saget B. M., Wang M. Z., Dinarello C. A., Skolnik P. R. Interleukin 1 induces HIV-1 expression in chronically infected U1 cells: blockade by interleukin 1 receptor antagonist and tumor necrosis factor binding protein type 1. Mol. Med. 1:1995;667-677.
15. Griffin G. E., Leung K., Folks T. M., Kunkel S., Nabel G. J. Activation of HIV gene expression during monocyte differentiation by induction of NF-kappa B. Nature. 339:1989;70-73.
16. Guan Z., Tetsuka T., Baier L. D., Morrison A. R. Interleukin-1 beta activates c-jun NH2-terminal kinase subgroups of mitogen-activated protein kinases in mesangial cells. Am. J. Physiol. 270:1996;F634-F641.
17. Hai T., Curran T. Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc. Natl. Acad. Sci. USA. 88:1991;3720-3724.
18. Hartig E., Loncarevic I. F., Buscher M., Herrlich P., Rahmsdorf H. A new cAMP response element in the transcribed region of the human c-fos gene. Nucleic Acids Res. 19:1991;4153-4159.
19. Henderson A. J., Conner R. I., Calame K. L. C/EBP activators are required for HIV-1 replication and proviral induction in monocytic cell lines. Immunity. 5:1996;91-101.
20. Hofmann B., Nishanian P., Nguyen T., Insiziengmay P., Fahey J. L. Human immunodeficiency virus proteins induce the inhibitory cAMP/protein kinase A pathway in normal lymphocytes. Proc. Natl. Acad. Sci. USA. 90:1993;6676-6680.
21. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270:1995;16483-16486.
22. Kharroubi A. E., Martin M. A. Cis-acting sequences located downstream of the human immunodeficiency virus type 1 promoter affect its chromatin structure and transcriptional activity. Mol. Cell. Biol. 16:1996;2958-2966.
23. Kobiershi L. A., Chu H. M., Tan Y., Comb M. J. cAMP-dependent regulation of proenkephalin by JunD and JunB: Positive and negative effects of AP-1 proteins. Proc. Natl. Acad. Sci. USA. 88:1991;10222-10226.
24. Kontny E., Kvanta A., Fredholm B. B. Activation of protein kinase C and elevation of cAMP interact synergistically to raise c-Fos and AP-1 activity in Jurkat cells. Eur. J. Pharmacol. 227:1992;333-338.
25. Kwok R. P., Lundblad J. R., Chrivia J. C., Richards J. P., Bachinger H. P., Brennan R. G., Roberts S. G., Green M. R., Goodman R. H. Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature. 370:1994;223-226.
26. Laspia M. F., Rice A. P., Mathews M. B. HIV-1 Tat protein increases transcription initiation and stabilizes elongation. Cell. 59:1989;283-292.
27. Lee K. A. W., Masson N. Transcriptional regulation by CREB and its relatives. Biochem. Biophys. Acta. 1174:1993;221-233.
28. Montminy M. R., Bilezikjian L. M. Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene. Nature. 328:1987;175-178.
29. Ng S. B., Tan Y. H., Guy G. R. Differential induction of the interleukin-6 gene by tumor necrosis factor and interleukin-1. J. Biol. Chem. 269:1994;19021-19027.
30. Nokta M., Pollard R. Human immunodeficiency virus infection: Association with altered intracellular levels of cAMP and cGMP in MT-4 cells. Virology. 181:1991;211-217.
31. Nokta M. A., Pollard R. B. Human immunodeficiency virus replication: Modulation by cellular levels of cAMP. AIDS Res. Hum. Retroviruses. 8:1992;1255-1261.
32. Ogryzko V. V., Schiltz R. L., Russanova V., Howard B. H., Nakatani Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell. 87:1996;953-959.
33. Rabbi M. F., Saifuddin M., Gu D. S., Kagnoff M. F., Roebuck K. A. U5 region of the human immunodeficiency virus type 1 long terminal repeat contains TRE-like cAMP-responsive elements that bind both AP-1 and CREB/ATF proteins. Virology. 233:1997;235-245.
34. Roebuck K. A., Brenner D. A., Kagnoff M. F. Identification of c-fos-responsive elements downstream of TAR in the long terminal repeat of human immunodeficiency virus type 1. J. Clin. Invest. 92:1993;1336-1348.
35. Roebuck K. A., Gu D. S., Kagnoff M. F. AP-1 cooperates with phorbol ester activation signals to increase HIV-1 expression. AIDS. 10:1996;819-826.
36. Roebuck K. A., Rabbi M. F., Kagnoff M. F. HIV-1 Tat protein can transactivate a heterologous TATAA element independent of viral promoter sequences and the trans-activation response element. AIDS. 11:1997;139-146.
37. Scholz W., Altman A. Synergistic induction of interleukin 2 receptor (TAC) expression on YT cells by interleukin 1 or tumor necrosis factor alpha in combination with cAMP inducing agents. Cell Signal. 1:1989;367-375.
38. Serkkola E., Hurme M. Synergism between protein-kinase C and cAMP-dependent pathways in the expression of the interleukin-1β gene is mediated via the activator-protein-1 (AP-1) enhancer activity. Eur. J. Biochem. 213:1993;243-249.
39. Van Lint C., Emiliani S., Ott M., Verdin E. Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. EMBO J. 15:1996;1112-1120.
40. Verdin E. DNase I-hypersensitive sites are associated with both long terminal repeats and with the intragenic enhancer of integrated human immunodeficiency virus type 1. J. Virol. 65:1991;6790-6799.
41. Verdin E., Paras P. Jr., Van Lint C. Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation. EMBO J. 12:1993;3249-32599.
42. Westendorp M. O., Shtrov V. A., Schulze-Osthoff K., Frank R., Kraft M., Los M., Krammer P. H., Droge W., Lehmann V. HIV-1 Tat potentiates TNF-induced NF-kappa B activation and cytotoxicity by altering the cellular redox state. EMBO J. 14:1995;546-554.
43. Westwick J. K., Weitzel C., Minden A., Karin M., Brenner D. A. Tumor necrosis factor alpha stimulates AP-1 activity through prolonged activation of the c-Jun kinase. J. Biol. Chem. 269:1994;26396-26401.
44. Ziff E. B. Transcription factor: A new family gathers at the cAMP response site. Trends Genet. 6:1990;69-72.